Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_provenance.
- NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_assertion description "[These results suggest that CD123 CAR T cells are a promising immunotherapy for the treatment of high-risk AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_provenance.
- NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_assertion evidence source_evidence_literature NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_provenance.
- NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_assertion SIO_000772 24030378 NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_provenance.
- NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_assertion wasDerivedFrom befree-20150227 NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_provenance.
- NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_assertion wasGeneratedBy ECO_0000203 NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP282824.RAenOMJw6eeUL7Fa0pNU9MHabIkaPDyJZJFh1acU56Nr4130_provenance.